AI assistant
Sending…
MESA LABORATORIES INC /CO/ — Director's Dealing 2021
Sep 1, 2021
33153_dirs_2021-09-01_fab12e29-1cbe-4d06-b1ce-e13bf97c37fd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MESA LABORATORIES INC /CO/ (MLAB)
CIK: 0000724004
Period of Report: 2021-09-01
Reporting Person: DINOIA GREGORY (SVP Commercial)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-01 | Restricted Stock Units - 4 | $ | A | 1004 | Acquired | Common Stock (1004) | Direct | |
| 2021-09-01 | Restricted Stock Units - 5 | $ | A | 780 | Acquired | Common Stock (780) | Direct | |
| 2021-09-01 | Non Qualified Stock Options | $268.85 | A | 3223 | Acquired | 2027-09-01 | Common Stock (3223) | Direct |
Footnotes
F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock
F2: RSUs that vest 1/3 on September 1, 2022, 1/3 on June 15, 2023 and 1/3 on June 15, 2024
F3: Not Applicable
F4: RSUs granted for navigation of Company through Covid-19
F5: RSUs that cliff vest on September 1, 2022
F6: NSOs that vest 1/3 on September 1, 2022, 1/3 on June 15, 2023 and 1/3 on June 15, 2024
More from MESA LABORATORIES INC /CO/
Major Shareholding Notification
2026
Apr 15
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Mar 13
Regulatory Filings
2026
Mar 9
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Director's Dealing
2025
Dec 5
Interim / Quarterly Report
2025
Nov 6
Regulatory Filings
2025
Nov 6